See also this year's filing and all EDGAR filings for this company.
PDF Report 0001260990_2012_Oncternal_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001260990, Oncternal Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 76,848,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 240,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,096,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 6,076,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,438,000 |
| 9 | ResearchAndDevelopmentExpense | 31,938,000 |
| 10 | remainder_Expenses | 1,055,000 |
| 11 | remainder_Revenues | 14,739,000 |
| 12 | remainder_NetIncome | 398,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 78,184,000 |
| 1 | Liabilities | 6,076,000 |
| 2 | Expenses | 48,431,000 |
| 3 | Revenues | 14,739,000 |
| 4 | StockholdersEquity | 72,108,000 |
| 5 | NetIncome | -33,294,000 |
| 6 | ComprehensiveNetIncome | -33,294,000 |
| 7 | BaseVar | 73,914,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.94 |
| 9 | EconomicCapitalRatio | 3.65 |
Edgar->Model Mapping
Feature Distribution
